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Context: Nature blesses human with a lot of natural products with a wide range of medicinal properties from plants, animals, marine animals, and 
microorganisms. Among these natural sources, plant origin drugs constitute around 25% which includes various secondary metabolites such as 
alkaloids, bioflavonoids, terpenes, saponins, glucosides, and lignans. The bioflavonoids belonging to the polyphenol group possess various therapeutic 
activities such as antioxidant, hepatoprotective, antibacterial, anti-inflammatory, anticancer, and antiviral.
Objectives: The main objective of this article is to collectively present the research data published worldwide about the anticancer activity of 
bioflavonoids by loading them in novel formulations. Thus, the present review explored the novel formulations of the bioflavonoids with improved 
pharmacokinetic properties along with the enhanced anticancer activity.
Methods: A systematic scientific review was made across the peer-reviewed scientific journals and books to collect the data pertaining to areas 
research related to the application of bioflavonoids for treatment of cancer using novel pharmaceutical formulations.
Results: The major drawback with bioflavonoids is its poor solubility and bioavailability, which restricts the usage of bioflavonoids in the treatment of 
cancer in the market worldwide. Novel drug delivery system seems to possess many benefits like site-specific drug delivery along with minimal side 
effects and improving its pharmaceutical and therapeutic properties of drugs compared to a conventional dosage form of bioflavonoids.
Conclusion: The scope for improvement of anticancer activity of bioflavonoids by incorporating in novel pharmaceutical formulations like 
nanoparticles is very high, and it has to be considered as a potential area of research. 
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INTRODUCTION
Mother Nature blessed the humans with a lot of sources with valuable 
therapeutic properties which serves as a root for various modern era 
drugs in all traditional systems of medicine as well as an allopathic 
system of medicine. Greeneries, animal, microbes, and minerals form 
the sources of drugs from our environment [1]. The natural products 
obtained from the greeneries are usually the secondary metabolites 
that are not highly involved in the primary stages of growth and 
development, but they play an important role in the defense mechanism 
of the plant thereby increasing the lifespan of the plants [2]. A wide 
range of secondary metabolites produced by the plants is found to 
possess therapeutic activity in humans also. Many of the secondary 
metabolites from the greeneries have been used as lead molecules 
for the development of many of the synthetic drug products for the 
treatment of chronic diseases such as cancer and brain disorders. A few 
to quote are alkaloids, bioflavonoids, terpenes, saponins, glucosides, 
and lignans, etc. Campothecin, paclitaxel, vincristine, vinblastine, 
digoxin, nicotine, ephedrine, lobeline, and emetine are few constituents 
derived from plants which have found a long way in the pharmaceutical 
industry in fabrication as drug product [3].
Bioflavonoids, belonging to the polyphenolic compounds, are found 
to be widely distributed in vegetables, cereals, and fruits forming 
a part of human diet. Many subclasses of flavonoids are identified 
which includes flavones, flavonols, flavanones, isoflavones, catechins, 
anthocyanins, dihydroflavonols, and chalcones [4-7] and are listed in 
Table 1 along with their food sources. Around 3000 bioflavonoids have 
been identified for their useful properties. In the recent years, there 
is a upswing interest in the beneficial efficiency of the polyphenolic 
compound especially the bioflavonoids [8]. The bioflavonoids are 
found to possess proven multifaceted therapeutic properties such 
as anti-atherosclerotic effect [9], anti-inflammatory effect [10-13], 
anti-thrombogenic effect, antitumor effect [14-16], antiosteoporotic 
effect [17], hepatoprotective  [18], and antimicrobial effect [19-21]. 
Bioflavonoids are proved to possess antioxidant property, hinders 
lipid peroxidation [4], and free radical scavenging property to a larger 
extent [22].
Cancer, a deadly disease of this era is found to have a multifaceted 
etiology which involves chemical, physical, environment, metabolic, and 
genetic factors, which forms direct or indirect cause for the disease and 
has been an area of recent concern for the development of the drugs for 
its effective treatment [23]. The rate of occurrence of cancer is found to 
be growing at an alarming rate and is predicted to have an occurrence 
of >15 million by the year 2020 [24,25]. Various treatment options are 
available for the treatment of cancer which includes, hormonal therapy, 
chemotherapy, surgery, and radiation therapy but the major drawbacks 
with the available treatment is its unwanted effects after its usage 
which provokes an alternative mode of treatment of cancer involving 
the natural products which are found to be safe and equally effective for 
the treatment of cancer at every stage.
Around 60% of the anticancer drugs are found to be of natural origin, 
and they are synthetically derived as drugs for the treatment of various 
cancers such as vincristine, vinblastine, actinomycin, taxoids, and 
anthracyclines [26]. Among the natural compounds, the flavonoids are 
known to possess many of the valuable pharmacological properties. 
The antioxidant property of bioflavonoids contributes to various 
other therapeutic activities such as anticancer, anti-inflammatory, 
antidiabetic, antiatherosclerotic, and antimutagenic. The major 
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mechanisms by which the bioflavonoids are shown to exhibit anticancer 
activity are by blocking the cell cycle, hindering angiogenesis and by 
urging apoptosis by which the further propagation of the cancer cells 
is ceased [27].
There are many number of studies which have investigated and proved 
the anticancer potential of various subclasses of bioflavonoids that 
have put them under the scientific area of research hoping to have a 
better treatment regimen for the treatment of one of the deadly disease 
like cancer. This has paved the way for the development of the novel 
formulations of bioflavonoids to overcome the conventional problems 
faced with it in formulating.
Novel drug delivery system development, a multifaceted area in the 
drug development which involves the modish design in regulating 
the pharmacodynamics, pharmacokinetics, immunogenicity, and non-
specific toxicity of the newly invented drugs [33]. This system alters the 
properties of the drugs by the usage of various polymers of natural or 
synthetic origin, biodegradable type, stimuli-sensitive type and even 
targeting of the drug to the specific organ can be achieved by various 
novel techniques, which have increased the burden on the scientists 
for deeper research in these areas. The novel drug delivery system 
shows many benefits compared to the conventional dosage forms, such 
as high bioavailability, improved remedy for chronic diseases, good 
patient compliance, lesser toxicity to the organs due to targeting, and 
so on which urges the drugs to be developed as novel formulations such 
as nanoparticles, liposomes, nanospheres, microspheres, hydrogels, 
ethosomes, and so on.
Novel techniques are introduced for formulating the natural products 
which are gaining the utmost importance in the field of medicine for 
the treatment of diseases such as cancer, brain disorders, and so on. 
Many bioflavonoids were evaluated for the anticancer activity and 
were proved to be much effective in the treatment of the same. A few 
of them with proved anticancer activity are fisetin, genistein, diadzein, 
quercetin, diosmetin, and so on [34]. Although bioflavonoids are proved 
to have pharmacological activity against the cancer cells, their usage 
is limited due to its various pharmacokinetic properties such as low 
solubility, less bioavailability which urges the pharmacy scientist to 
convert this much useful natural product into a novel formulation. This 
is considered to be the latest area of research in the pharmaceutics.
The flavonoids are found too much useful compounds for treating 
cancer by various mechanisms such as targeting apoptosis signal and 
inducing the process, inhibition of epidermal growth factor receptor 
and extracellular signal-regulated kinases pathway, modulating the 
Raf/MEK/ERK signaling pathway, reducing the notch signaling pathway, 
inhibition of Wnt/β-catenin pathway, inhibiting the transcription factor 
signal transducer and activator of transcription 3, triggering the Nf-ϏB 
and Nrf2 signals, and so on [25].
This review aims in bringing into limelight the bioflavonoids possessing 
the anticancer potential that is formulated into the novel formulations 
such as nanoparticles, nanospheres, liposomes, microspheres, 
hydrogels, ethosomes, nanoemulsions, and so on which will surely create 
a revolution in the field of medicine in curing various human ailments.
BIOFLAVONOIDS WITH ANTICANCER ACTIVITY AND THEIR 
NOVEL FORMULATIONS
Quercetin
Quercetin, a dietary flavonoid is considered to be the pillar for many 
of the other flavonoids. It is found to be distributed naturally in many 
of the diet foods such as tea, berries, apple, onion, vegetables and 
nuts, seeds, barks, leaves, and flowers. It is chemically 3, 5, 7, 3’, 4’ 
pentahydroxy flavones and it is found to show many pharmacological 
properties such as cardioprotective effect [35], antioxidant activity, 
analgesic activity, antiviral activity, antidiabetic activity, anticancer 
activity, immunosuppressor activity, antithyroid activity, and so 
on. The anticancer activity was shown to be exhibited by various 
mechanisms such as abolishing the free radicals, reaction with the 
estrogen receptors, proteins and transcription factors, retarding cell 
proliferation, initiation of apoptosis, and reducing metalloproteinase 
2 and 9 expression. Quercetin, although, has many of the therapeutic 
properties its use is limited due to many of the drawbacks such as 
less bioavailability and poor aqueous solubility and so to improve its 
physicochemical properties and also to improve its targeting property 
the novel drug delivery systems such as nanoparticles, niosomes, and 
liposomes can be developed for quercetin.
Saha et al. formulated and evaluated the nanoparticles of polylactic 
coglycolic acid with hydrophobic anticancer drugs of anthracycline 
origin such as paclitaxel, doxorubicin, and bioflavonoid quercetin, a 
chemoprevention by single emulsion solvent evaporation method. The 
surface modification of the bioflavonoid nanoparticles was carried 
out using the polymers of biological origin such as histones or bovine 
serum albumin. The formulated nanoparticles were evaluated for their 
physicochemical properties such as particle size analysis, zeta potential, 
entrapment efficiency, drug loading capacity, Fourier-transform 
infrared, differential scanning calorimetry, thermogravimetric analysis, 
scanning electron microscope, transmission electron microscopy, and 
in vitro drug release and the effects were found to be satisfactory. The 
main problem associated with the anticancer drugs is the opsonization 
which leads to the clearance of the drug by liver and spleen which was 
overcome by the surface modification which helps the targeting of the 
drug to cancer cells and for overcoming the multidrug resistance [36].
Devendiran et al. green synthesized gold nanoparticles containing 
the drug doxorubicin and the antioxidant bioflavonoid quercetin as a 
reducing agent with dextran sulfate as a stabilizing agent, adorned with 
folic acid and evaluated for the treatment of breast cancer. They were 
evaluated for their in vitro physicochemical properties and biological 
properties and were found to be stable. The anticancer activity was 
carried out using the human breast cell lines MCF-7 using MTT assay, 
and it was proved that the formulated nanoparticles represented a 
potential targeted drug delivery for better treatment of cancer [37].
Table 1: Subclasses of flavonoids with their dietary sources
S. No. Subclass Dietary sources Examples of bioflavonoids
1. Flavonols Apple, tomato, cherry, tea, garbanzo beans, onions, and red wine Myricetin, kaempferol, quercetin, rutin
2. Flavones Celery, bell peppers, parsley, apples, and thyme Chrysin, luteolin, and apigenin
3. Flavanols Bananas, blueberries, peaches, tea, pears, and apple Gallocatechin and catechin
4. Flavanones Grapes and orange Hesperidin, eriodictyol, and naringenin
5. Isoflavones Soybean and legumes Daidzein, glycetin, genistein, and formononetin
6. Anthocyanidins Oranges, olives, red onion, sweet potato, kidney beans, black beans Cyanidins, pelargonidin, peonidin, petunidin
Many  epidemiological  studies  have  proved  the 
anticancer potential of various subclasses of bioflavonoids. A few
 to quote are polymethoxyflavones are proved to hinder the 
growth  of  human  leukemic  cell  lines  (HL  60)  [28],  nobiletin 
hindered  the  mushrooming  and  relocation  of  human  umbilical 
endothelial cells of human prostate, breast, skin and colon carcinoma cell 
lines [29],  luteolin -7 methyl  ether exhibited the celltoxicity  towards the 
human  lung  cancer  cell  lines  [30],  genistein,  genistin,  daidzein, 
biochanin A belonging to isoflavonones subclass of  bioflavonoids 
are  found  to  hinder  the  growth  of  human  bladder  and  murine 
camcer  cell  lines  [31],  quercetin  was  found  to  be  useful  in  the 
treatment of gastric, pancreatic and thyroid cancer [32].
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Pandey et al. synthesized nanoparticles of quercetin embedded with 
polylactic acid by novel emulsified nanoprecipitation method and 
evaluated for its anticancer activity in human breast cancer cell lines. 
The physicochemical properties evaluation showed that the flavonoid 
release from the polymer matrix showed a sustained release and in vitro 
cytotoxicity studies proved the efficiency of the nanoformulation for 
treating cancer [38].
Sahu et al. formulated the quercetin nanoparticles of biocompatible 
nature using the biocompatible and nonbiodegradable polymers such 
as ethyl cellulose and Tween 80 by the nanoprecipitation technique 
for the topical prolonged delivery of the bioflavonoid for the treatment 
of skin cancer. The formulated nanoparticles were evaluated for their 
physicochemical and ex vivo skin penetration studies. From the studies, 
it was concluded that the quercetin formulated as nanoparticles can 
be sustained in the drug release thereby intending the decrease in the 
frequency and dose of the drug urging the research of quercetin novel 
formulations in the area of anticancer study [39].
Fisetin
Fisetin, known popularly as natural brown [40], is chemically 
3,3’,4’,7-tetrahydroxy flavone and a dietary flavonoid found in the 
foods such as tomatoes, onions, mangoes, apples, strawberries, 
cucumbers, kiwis, nuts, and grapes [40]. Fisetin was proved to possess 
many therapeutic activities such as antioxidant activity [41], anti-
inflammatory activity [42,43], antidiabetic activity [40], antiviral 
activity [44,45], cardioprotective effect, and anticancer activity [46,47]. 
Fisetin bioflavonoid was found to possess much effective therapeutic 
activity against cancer through various mechanisms such as inducing 
apoptosis of cancer cells, activation of 5’ Adenosine monophosphate-
activated protein kinase and acetyl coenzyme A carboxylase [48-50] 
and so on. Since, cancer is the dreadful disease which has gained specific 
attention of the researchers and fisetin a natural bioflavonoid in novel 
formulation possesses many advantages of enhanced pharmacokinetic 
properties, safety, economic, and specific organ targeting which can 
greatly help the physicians to treat cancer in a better means.
Ragelle et al. formulated fisetin a well proved antitumor agent to 
improve its aqueous solubility into an nanoemulsion formulation and 
proved its improvement in pharmacokinetic property and its antitumor 
therapeutic activity on intraperitoneal administration of the fisetin 
nanoemulsion in Lewis lung carcinoma affected mice [51].
Bothiraja et al. formulated fisetin a flavonoid with poor water 
solubility and the one that undergoes more metabolism in vivo, as a 
nanocochelates, by trapping technique in which the flavonoid loaded 
dimyristoyl-phosphatidyl choline loaded liposomal vesicles were 
converted into the nanochelates in the presence of ca2+ ions. This 
nanochelates were proved to be much stable and more effective in the 
treatment of human breast cancer [52].
Ghosh et al. nanoparticles of fisetin using human serum albumin 
by desolvation technique and evaluated for their physicochemical 
properties and cytotoxic activity. The formulated albumin 
nanoparticles were found to possess antioxidant activity and also 
effective against the breast cancer MCF-7 cell lines. The nanoparticles 
were found to be much effective in targeting the flavonoid fisetin to 
the cancer cells [53].
Genistein
Genistein, a nutraceutical [54] soy isoflavone and a plant estrogen, a 
flavanoid found in soybeans and soy food is found to posesses a variety 
of pharmacological activities including the anticholesterol activity, 
antioxidant activity, antidiabetic activity, menopausal syndrome, and 
anticancer activity [55]. Although genistein is a proved isoflavone for 
the treatment of cervical, breast and prostrate cancer, its use in this 
area is limited due its solubility and bioavailability, which initiates its 
formulation development as nanoformulation which can overcome this 
limitation and prove its potentiality in the treatment of cancer.
Zhang et al. produced flavonoid, genistein d-α-tocopheryl polyethylene 
glycol 1000 succinate b polycaprolactone nanoparticles by modified 
nanoprecipitation method. This novel formulation of the flavonoid was 
found to be effective in improving the solubility characteristics of the 
antitumor flavonoid genistein and as a valuable antitumor agent in 
treating cervical cancer as tested in the HeLa xenograft tumor model in 
BALB/c nude mice [56].
Phan et al. formulated the novel liposomal formulation containing 
the most proven flavonoid with antitumor potential of genistein for 
proving its efficacy in breast, ovarian, and prostate cancers. Genistein 
conventional and stealth liposomes were formulated using the 
phospholipids and cholesterol, and its antioxidant efficacy retention was 
proved by the neutralization of peroxides and microscopic fluorescent 
probe oxidation assays. The anticancer efficacy of the genistein loaded 
liposomal formulation was proved in human and mouse cancer cell 
lines which was indicated by the measurement of specific proapoptotic 
activity [57].
Patel et al. studied the novel formulation of isoflavone genistein using 
the polymers in varying ratios of chitosan and Eudragit and evaluated 
them for their physicochemical properties which proved them to be 
valuable drugs for the treatment of dreadful disease cancer [58].
Cai et al. formulated and evaluated the chitosan linked and folic acid 
linked nanoparticle containing bioflavonoid genistein for its improved 
activity in cervical cancers. It was proved from the study that the tagging 
of folic acid to the genistein nanoparticles improved its cytotoxicity 
studies as proved by MTT assay as compared to the genistein loaded 
nanoparticles in the treatment of cervical cancers [59].
Aditya et al. showed the efficacy of coloading of curcumin and genistein 
in nanostructured lipid carriers in the treatment of antiprostrate cancer. 
It was proved from the studies that coloading improved the flavonoidal 
loading efficiency as well as the cancer cell growth inhibition property 
of the flavonoids to a greater extent [60].
Isorhamnetin
Isorhamnetin, a metabolite of quercetin, which is chemically 
O-methylated flavonol found in plenty in blackberries, cherries, pears, 
and apples [61]. The flavonoid is a highly active molecule showing wide 
variety of pharmacological activities such as antidiabetic, antioxidant, 
cardiovascular, anticancer, anti-inflammatory, hepatoprotective, and 
anti-obesity agent [61]. Isorhamnetin was proved to be an effective 
anticancer agent for treating lung cancers [62-64]. However, its 
targeting capacity is poor due to the poor aqueous solubility and 
bioavailability, which proves the necessity for the development of 
the nanoformulations for the most eligible flavonoid molecule in the 
treatment of cancer.
Settu and Vaiyapuri studied the effect of poly lactic-co-glycolic acid 
isorhamnetin nanoparticles on HepG2 cancer cell lines and concluded 
that the nanoformulation of isorhamnetin produced a significant 
increase in the inhibition of proliferation as compared to the plain 
isorhamnetin [65].
Kaempferol
Kaempferol, a plant nutrient found widely distributed in many of the 
plant families, such as Aspleniaceae, Aspidiaceae, Polypodiaceae, 
Blechnaceae, Cyatheaceae, Equisetaceae, and Ophioglossaceae and is 
present as a major constituent inedible foods such as onion, mustard, 
turnip greens, tea, grapefruit, tea, cucumber, fennel, and peach [66,67]. 
Kaempferol based plant food intake reduces the risk of various types 
of cancers such as lung cancer, pancreatic cancer, ovarian cancer, 
and gastric cancer and many of the cardiovascular disease. From 
various epidemiological studies, kaempferol was also proved to 
possess antioxidant activity, anti-inflammatory activity, antidiabetic 
activity [68], and antimicrobial activity [69]. Although there are many 
pharmacological activities; their usefulness is limited due to less oral 
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bioavailability and low water solubility. Hence, researchers are carried 
out to improve its pharmacokinetic properties, in turn, the therapeutic 
benefits of the flavonoid be made completely available to the suffering 
patients.
Luo et al. studied the comparative effect of the most proven 
bioflavonoid kaempferol formulated as nanoparticle on the ovarian 
cancer cells and normal cells. The non-ionic polymers poly(ethylene 
oxide)- poly(propylene oxide)-poly(ethylene oxide) and poly (DL- Lactic 
acid-co-glycolic acid) were used to formulate the nanoparticles 
containing kaempferol, and it was proved that both the polymers 
showed an improved efficacy in decreasing the viability of cancer cells 
and normal cells with the PLGA kaempferol nanoparticle being superior 
in its specific anticancer activity [70].
Raghavan et al. synthesized gold nanoparticles contain the flavonol, 
kaempferol, and proved their cell toxic effect on the MCF-7 cancer 
cell line. The study results proved that the nanoparticles were found 
to be effective by reducing the vivacity of MCF-7 breast cancer cells as 
confirmed by the ethidium bromide-acridine orange staining method 
and urged programmed cell death as confirmed by the CyQuant assay 
method [71].
Luteolin
Luteolin, a flavone found in foods which we intake which includes, 
cabbage, carrots, apple skin, green pepper, and chamomile tea. It was 
also studies for various therapeutical activities such as antitumorigenic, 
anti-inflammatory, antidiabetic, and antioxidant [40]. Luteolin 
requires high bioavailability to exhibit its pharmacological activity 
in vivo, and due to its low bioavailability in vivo by the oral route, the 
novel formulation development may prove to be helpful to achieve its 
maximum pharmacological activity.
Majumdar et al. studied the effect of the bioflavonoid luteolin in 
nanoparticle formulation to improve its aqueous solubility, bioavailability, 
and anticancer efficacy of the flavonoid. PLA-PEG-OMe polymer was 
used for formulating luteolin nanoparticles and the evaluation of the 
formulated nanoparticles for lung, neck, and head anticancer activity was 
done by in vitro and in vivo methods. The various cell lines such as H292 
and Tu212 were used for the study which showed the inhibitory activity 
of the nanoparticles against the cancer cell lines and the in vivo anticancer 
activity by tumor xenograft mouse model which also proved a significant 
inhibitory effect on the tumor cells [72].
Hesperetin
Hesperidin, a flavone glycoside, an abundant plant constituent present 
in limes and lemons, was studied for many pharmacological effects, 
such as antidiabetic, antioxidant, anticancer, anti-inflammatory effects, 
and so on. It was found to prevent the cell death. Although it possesses 
many pharmacological activities, its use in the field of medicine is 
limited due to its limited aqueous solubility and bioavailability, which 
can be rectified to a certain extent by formulating the flavonoid as 
nanoformulation which can also serve as a measure to target the 
flavonoid to cancer cells.
Gurushankar et al. formulated, characterized, and evaluated the 
bioflavonoid hesperetin nanoparticles produced using the polymers 
Eudragit E 100 by the nanoprecipitation technique for its efficiency in 
treating oral cancer. The results concluded that the nanoparticles of the 
flavonoid were efficient in producing the toxic effect on the cancer cells 
on a dose-dependent manner, changes in the mitochondrial membrane 
potential, improved intracellular reactive oxygen species, necrobiotic 
morphological changes, and also DNA damage, which urges its 
development as novel particles for the treatment of dreadful diseases  [73].
Naringenin
Naringenin, chemically a flavanone glycoside is (4’,5,7 –trihydroxyflavanone) 
found to be a major constituent in various citrus fruits [74], 
tomatoes [75], cherries [76], and cocoa is found to be potent anticancer 
agent in treating liver and gastric cancer [77,78]. It was also studied 
for its antioxidant, liver protective, anti-inflammatory, cardiovascular, 
gastrointestinal, and immunity-boosting effects [79-84]. Naringenin 
was found to increase the therapeutic activity of anticancer drugs like 
doxorubicin, and the drug seems to possess cardiotoxicity on long-
term usage, and naringenin seems to possess low bioavailability and 
solubility which makes it’s clear to make modifications in formulations 
for increasing its pharmacokinetic parameters and also to make the 
flavonoid disease specific.
Winarti et al. studied the in vitro anticancer activity of the flavonoid 
naringenin nanoparticles formulated using the chitosan polymer. T47D 
breast cancer cell lines were used for the study and were found that the 
encapsulated naringenin showed an increased cell toxic effect, and also 
it resulted in the increased cellular uptake and caused induction in the 
programmed cell death [85].
Parashar et al studied the naringenin loaded in polycaprolactone 
polymer as nanoparticles linked with the hyaluronic acid to increase 
the target specificity of the flavonoid which is a potential drug candidate 
in treating the lung cancer. The results revealed that the flavonoid 
naringenin is a potential candidate for treating the lung cancer as 
proved by the cell toxicity studies on A549 cells and J774 cells [86].
Rutin
Rutin, a bioflavonoid found in buckwheat bran, citrus fruits, black 
tea, clove, rose, rue possesses many of the therapeutic activities 
including the antioxidant activity [87], cardioprotective activity, anti-
atherosclerotic [36], anticancer activities [88], and many other useful 
pharmacological properties. Although it has various pharmacological 
properties, its exploration in the field of medicine is much reduced 
due to the low solubility and bioavailability, which can be overcome by 
making modifications in the formulation using various polymers which 
are of a degradable type and producing the nanoformulations.
Asfour and Mohsen formulated and studied the effect of the less soluble 
bioflavonoid rutin as nanospheres using the polymer Eudragit S 100 
with various concentration of stabilizer poloxamer 188, to target the 
cancerous cells in the colon region of the body. They proved the rutin 
nanospheres efficiency in the treatment of colonic cancer as showed by 
the two-fold increased activity of the nanoformulation in the cell toxic 
effect of the bioflavonoid rutin [89].
Ahmad et al. developed a nanoemulsion formulation of the bioflavonoid 
rutin and evaluated for its anticancer activity on the prostatic cancer 
cell lines PC-3, proving its efficiency in treating prostatic cancer [90].
CONCLUSION
Many of the daily foods can be used as drugs. Among them, the 
flavonoids which find their source in many of the daily foods is proved 
through many experiments to possess potential therapeutic activities 
in treating many of the diseases. Cancer is considered to be the disease 
which is of major concern worldwide. Due to the various side effects in 
using the conventional system of medicine, modern developments have 
been in full wing in using these plant-derived constituents, especially 
the flavonoids for the formulation as novel drug delivery system such 
as nanoparticles, nanoemulsions, and liposomes which will be a boon 
to the human society in treating cancer.
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